Test
Intended for the in vitro quantitative measurement of antibodies directed to β2-Glycoprotein I in human serum and plasma to aid in the diagnosis of antiphospholipid syndrome (APS) and to evaluate the thrombotic risk in patients with systemic lupus erythematosus (SLE).
For Use With (Application) | In-vitro quantitative measurement of Antibodies directed to beta2-Glycoprotein I in Human Serum and Plasma to aid in the diagnosis of antiphospholipid syndrome |
---|